The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
The widespread use of primaquine (PQ) radical cure for P. vivax, is constrained by concerns over its safety. We used routinely collected patient data to compare the overall morbidity and mortality in patients treated with and without PQ without prior testing of Glucose-6-Phosphate-Dehydrogenase (G6P...
Saved in:
Main Authors: | Kamala Thriemer (Author), Jeanne-Rini Poespoprodjo (Author), Enny Kenangalem (Author), Nicholas M Douglas (Author), Paulus Sugiarto (Author), Nicholas M Anstey (Author), Julie Anne Simpson (Author), Ric N Price (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia.
by: Daniel A Lampah, et al.
Published: (2011) -
Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study.
by: Siobhan Langford, et al.
Published: (2015) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
by: Walter R J Taylor, et al.
Published: (2023) -
Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia.
by: Zuleima Pava, et al.
Published: (2020) -
An analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testing.
by: Douglas H Kerlin, et al.
Published: (2012)